These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27017703)

  • 21. [Experimental study of antidepressant effects of GB-115 dipeptide].
    Kolik LG
    Eksp Klin Farmakol; 2011; 74(1):3-5. PubMed ID: 21476266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.
    Hattesohl M; Feistel B; Sievers H; Lehnfeld R; Hegger M; Winterhoff H
    Phytomedicine; 2008 Jan; 15(1-2):2-15. PubMed ID: 18160026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiolytic effects of benzalphthalides.
    Zamilpa A; Herrera-Ruiz M; del Olmo E; López-Pérez JL; Tortoriello J; San Feliciano A
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3483-6. PubMed ID: 15982883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of chalcones--a flavonoid subclass, for, their anxiolytic effects in rats using elevated plus maze and open field behaviour tests.
    Jamal H; Ansari WH; Rizvi SJ
    Fundam Clin Pharmacol; 2008 Dec; 22(6):673-81. PubMed ID: 19049672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of anxiolytic activity of spray dried powders of two South Brazilian Passiflora species.
    Reginatto FH; De-Paris F; Petry RD; Quevedo J; Ortega GG; Gosmann G; Schenkel EP
    Phytother Res; 2006 May; 20(5):348-51. PubMed ID: 16619361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115.
    Boyko SS; Kolyvanov GB; Zherdev VP; Gudasheva TA; Kiryanova EP; Seredenin SB
    Bull Exp Biol Med; 2007 Sep; 144(3):312-3. PubMed ID: 18457023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic action of urocortin 3 fragments in mice.
    Telegdy G; Kádár K; Tóth G
    Behav Brain Res; 2011 Sep; 222(2):295-8. PubMed ID: 21457730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M; Zarrindast MR; Bina P
    Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Dipeptide Ligand of TSPO.
    Deeva OA; Pantileev AS; Rybina IV; Yarkova MA; Gudasheva TA; Seredenin SB
    Dokl Biochem Biophys; 2019 May; 484(1):17-20. PubMed ID: 31012004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats.
    Açikmeşe B; Haznedar S; Hatipoğlu I; Enginar N
    Behav Pharmacol; 2012 Apr; 23(2):215-9. PubMed ID: 22327020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel β-lactoglobulin-derived peptides, wheylin-1 and -2, having anxiolytic-like activity in mice.
    Yamada A; Mizushige T; Kanamoto R; Ohinata K
    Mol Nutr Food Res; 2014 Feb; 58(2):353-8. PubMed ID: 24039078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Nov; 742():94-101. PubMed ID: 25199966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrahippocampal infusion of the Ih blocker ZD7288 slows evoked theta rhythm and produces anxiolytic-like effects in the elevated plus maze.
    Yeung M; Dickson CT; Treit D
    Hippocampus; 2013 Apr; 23(4):278-86. PubMed ID: 23280856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice.
    Rabbani M; Sajjadi SE; Vaseghi G; Jafarian A
    Fitoterapia; 2004 Jul; 75(5):457-64. PubMed ID: 15261383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effect of Copaifera reticulata Ducke copaiba oil in rats tested in the elevated plus-maze: an ethological analysis.
    Curio M; Jacone H; Perrut J; Pinto AC; Filho VF; Silva RC
    J Pharm Pharmacol; 2009 Aug; 61(8):1105-10. PubMed ID: 19703355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic effects of Salvia reuterana Boiss. on the elevated plus-maze model of anxiety in mice.
    Rabbani M; Sajjadi SE; Jafarian A; Vaseghi G
    J Ethnopharmacol; 2005 Oct; 101(1-3):100-3. PubMed ID: 15994042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.